MedTrace Logo

Clinical Trial of YYC301 P3 for Treatment of Osteoarthritis of the Knee

NCT05362851 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 692

Last updated 2022-05-05

No results posted yet for this study

Summary

A Multi-center, Double-blinded, Randomized, Active-controlled, Parallel Design, phase 3 Clinical Trial to Evaluate the Efficacy and Safety of YYC301 in Patients with Osteoarthritis of the Knee Joint

Conditions

  • Osteoarthritis, Knee

Interventions

DRUG

YYC301-1 & YYC301-2 & YYC301-3

YYC301-1: Subjects take the investigational products once a day YYC301-2: Subjects take the investigational products once a day YYC301-3: Subjects take the investigational products once a day

DRUG

YYC301 placebo & Celecoxib 200mg

comparator medication

Sponsors & Collaborators

  • CliPSBnC

    collaborator UNKNOWN

  • Yooyoung Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Kyoung Ho Yoon, Ph.D. · Kyunghee University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-11
Primary Completion
2023-01-31
Completion
2023-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05362851 on ClinicalTrials.gov